EGFR and neoplasm: Specifically, compared with the other patients with the G719A mutation, the third patient (P5) (Figure 1A) did not experience any shrinkage of the tumor lesion after treatment, and NGS testing suggested S899N and D1083V co-mutations of EGFR; however, the significance of these co-mutations is currently unknown.